Date: 2015-07-07
Type of information: Collaboration agreement
Compound:
Company: Incyte (USA - DE) Vanderbilt University Medical Center (USA - TN)
Therapeutic area: Cancer - Oncology
Type agreement: collaboration R&D
Action mechanism:
Disease:
Details: * On July 7, 2015, Incyte announced that it has entered into a multi-year research support and collaboration agreement with Vanderbilt-Ingram Cancer Center (VICC) at Vanderbilt University Medical Center (VUMC), whereby Incyte will provide funding for certain aspects of Vanderbilt\'s cancer research activities. This alliance is designed to develop an improved understanding of basic cancer biology and the mechanisms of action of certain Incyte -proprietary compounds, as well as identify and develop novel approaches to patient selection which may enable new therapeutic opportunities in oncology.
Financial terms:
Latest news:
